CDK Inhibition Reverses Acquired 5-Fluorouracil Resistance in Hepatocellular Carcinoma Cells

BACKGROUND: 5-Fluorouracil (5-FU) has been widely applied in treating cancers. However, its usage is largely limited in hepatocellular carcinoma (HCC), due to acquired resistance. Here, we aim to identify target proteins and investigate their roles in 5-FU sensitivity of HCC cells. METHODS: Mass spe...

Descripción completa

Detalles Bibliográficos
Autores principales: Pu, Yiyi, Yan, Dongmei, Tu, Linglan, Cheng, Liyan, Yu, Jie, Li, Zhuduo, Zheng, Xiaoliang, Wang, Xinbao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933118/
https://www.ncbi.nlm.nih.gov/pubmed/35308136
http://dx.doi.org/10.1155/2022/6907057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933118/
https://www.ncbi.nlm.nih.gov/pubmed/35308136
http://dx.doi.org/10.1155/2022/6907057

Ejemplares similares